HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (14) Citing Articles via Google Scholar Google Scholar Articles by Corbould, A Search for Related Content PubMed PubMed Citation Articles by Corbould, A

Prince Henry’s Institute of Medical Research, Monash Medical Centre, Block E, Level 4, Clayton Road, Clayton, Victoria 3168, Australia

(Requests for offprints should be addressed to A Corbould; Email: anne.corbould{at}princehenrys.org)

Adipose tissue plays a central role in determining whole body insulin sensitivity. Several aspects of adipose cell function are regulated by androgens. Given that high androgen levels and insulin resistance are linked in women, we proposed that androgens may influence insulin-mediated glucose metabolism in adipose cells. Preadipocytes harvested from s.c. adipose tissue of healthy women aged 37 ± 5 years were differentiated in vitro, then treated with testosterone (T) and/or androgen receptor (AR) antagonists (cyproterone acetate, flutamide) for 48 h. Maximal insulin-stimulated glucose uptake (insulin 10 nM) and increment following insulin stimulation were significantly impaired in cells treated with T 10 and 100 nmol/l. This defect was abolished by cyproterone acetate and partially reversed by flutamide. The effect of T could not be accounted for by altered differentiation status of the adipocytes. In the glucose metabolic pathway of insulin signaling, treatment of cells with T 10 nmol/l did not alter insulin-stimulated phosphorylation of insulin receptor substrate-1 or Akt, but insulin-stimulated phosphorylation of protein kinase C (PKC) was impaired. Insulin signaling via the mitogenic/gene regulatory pathway, as assessed by extracellular signal-regulated kinase phosphorylation, was unchanged. We conclude that (1) T, or an androgenic metabolite of T, induces insulin resistance in adipocytes of women, selective for metabolic signaling pathways; (2) this defect is via AR; and (3) the defect in signaling is independent of phosphatidylinositol 3-kinase activation and involves impaired phosphorylation of PKC. These findings are relevant to understanding the pathogenesis of insulin resistance in hyperandrogenic women.

This article has been cited by other articles:

				L. Moran and H. Teede Metabolic features of the reproductive phenotypes of polycystic ovary syndrome Hum. Reprod. Update, July 1, 2009; 15(4): 477 - 488. [Abstract] [Full Text] [PDF]

				R. Homburg Androgen circle of polycystic ovary syndrome Hum. Reprod., July 1, 2009; 24(7): 1548 - 1555. [Abstract] [Full Text] [PDF]

				Z. Q. Wang, Z. E. Floyd, J. Qin, X. Liu, Y. Yu, X. H. Zhang, J. D. Wagner, and W. T. Cefalu Modulation of Skeletal Muscle Insulin Signaling With Chronic Caloric Restriction in Cynomolgus Monkeys Diabetes, July 1, 2009; 58(7): 1488 - 1498. [Abstract] [Full Text] [PDF]

				T. P. Ciaraldi, V. Aroda, S. Mudaliar, R. J. Chang, and R. R. Henry Polycystic Ovary Syndrome Is Associated with Tissue-Specific Differences in Insulin Resistance J. Clin. Endocrinol. Metab., January 1, 2009; 94(1): 157 - 163. [Abstract] [Full Text] [PDF]

				A. Perciaccante, A. Fiorentini, R. Valente, and L. Tubani Polycystic Ovary Syndrome: Androgens, Autonomic Nervous System, and Hypertension Hypertension, July 1, 2007; 50(1): e7 - e7. [Full Text] [PDF]